• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环转化生长因子β(1)作为肝硬化肝功能损害的指标。

Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.

作者信息

Flisiak R, Pytel-Krolczuk B, Prokopowicz D

机构信息

Department of Infectious Diseases, Medical Academy of Bialystok, Bialystok, Poland.

出版信息

Cytokine. 2000 Jun;12(6):677-81. doi: 10.1006/cyto.1999.0660.

DOI:10.1006/cyto.1999.0660
PMID:10843744
Abstract

In the liver, transforming growth factor (TGF) -beta(1)is primarily responsible for activation of fat-storing cells, which are the main source of extracellular matrix proteins. Their deposition play a key role in the development of liver cirrhosis. The aim of this study was to evaluate plasma TGF-beta(1)in patients with different stages of liver cirrhosis and its possible use as an indicator of liver function impairment. TGF-beta(1)was measured in the plasma of 40 patients with liver cirrhosis. To estimate possible effect of liver insufficiency on plasma TGF-beta(1), patients were divided into three groups: A, B and C, univocal with Child-Pugh classes. Normal values were collected from 13 healthy volunteers. Liver cirrhosis resulted in a significant increase of plasma concentration of TGF-beta(1)(39.3+/-3.8 ng/ml), which doubled normal values (18.3+/-1.6 ng/ml). The highest concentrations were observed in alcoholic patients (44.4+/-4.7 ng/ml). TGF-beta(1)level increased depending on the degree of liver insufficiency, demonstrated by a significant positive correlation with Child-Pugh score (r=0.591). Values in group A were similar to normal, but were significantly elevated in groups B and C. These findings suggest possible use of plasma TGF-beta(1)measurement as an indicator of liver function impairment and possible marker of hepatic fibrosis progression in cirrhotic patients.

摘要

在肝脏中,转化生长因子(TGF)-β1主要负责激活贮脂细胞,而贮脂细胞是细胞外基质蛋白的主要来源。它们的沉积在肝硬化的发展过程中起关键作用。本研究的目的是评估不同阶段肝硬化患者的血浆TGF-β1水平及其作为肝功能损害指标的可能性。检测了40例肝硬化患者血浆中的TGF-β1。为评估肝功能不全对血浆TGF-β1的可能影响,将患者分为A、B、C三组,分别对应Child-Pugh分级。从13名健康志愿者中收集了正常值。肝硬化导致血浆TGF-β1浓度显著升高(39.3±3.8 ng/ml),是正常值(18.3±1.6 ng/ml)的两倍。酒精性肝病患者的浓度最高(44.4±4.7 ng/ml)。TGF-β1水平随肝功能不全程度的增加而升高,与Child-Pugh评分呈显著正相关(r = 0.591)。A组的值与正常相似,但B组和C组显著升高。这些发现表明,检测血浆TGF-β1可能作为肝硬化患者肝功能损害的指标以及肝纤维化进展的可能标志物。

相似文献

1
Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.循环转化生长因子β(1)作为肝硬化肝功能损害的指标。
Cytokine. 2000 Jun;12(6):677-81. doi: 10.1006/cyto.1999.0660.
2
Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.血浆金属蛋白酶组织抑制剂-1和转化生长因子β1——慢性乙型和丙型肝炎患者肝纤维化可能的非侵入性生物标志物。
Hepatogastroenterology. 2002 Sep-Oct;49(47):1369-72.
3
Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.血清透明质酸反映酒精性肝病中的肝纤维化形成,可作为纤维化的标志物。
Hepatology. 1996 Dec;24(6):1399-403. doi: 10.1002/hep.510240615.
4
[Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis].[转化生长因子β1基因多态性对乙型肝炎病毒所致肝硬化的影响]
Zhonghua Yi Xue Za Zhi. 2005 Apr 20;85(15):1021-6.
5
Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.乙型急性病毒性肝炎中的血浆转化生长因子β1、金属蛋白酶-1和金属蛋白酶组织抑制剂-1
Regul Pept. 2005 Nov;131(1-3):54-8. doi: 10.1016/j.regpep.2005.06.002.
6
[Diagnostic value of five serum markers for liver fibrosis].[五种血清标志物对肝纤维化的诊断价值]
Zhonghua Gan Zang Bing Za Zhi. 2001 Jun;9(3):148-50.
7
Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma.循环转化生长因子-β1对不可切除肝细胞癌免疫及预后的潜在影响
Liver Int. 2004 Feb;24(1):21-8. doi: 10.1111/j.1478-3231.2004.00882.x.
8
[Endogenous digitalis-like factor in liver cirrhosis and cholestasis].[肝硬化和胆汁淤积中的内源性类洋地黄因子]
Z Gastroenterol. 1993 Feb;31 Suppl 2:20-3.
9
Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.肝硬化患者循环血管内皮生长因子及其可溶性受体:与肝功能损害的可能关联。
Cytokine. 2008 Oct;44(1):14-7. doi: 10.1016/j.cyto.2008.06.002. Epub 2008 Jul 25.
10
The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.谷草转氨酶/谷丙转氨酶比值作为原发性胆汁性胆管炎患者肝硬化的一项指标。
Liver Int. 2006 Sep;26(7):840-5. doi: 10.1111/j.1478-3231.2006.01304.x.

引用本文的文献

1
Pleiotropic Action of TGF-Beta in Physiological and Pathological Liver Conditions.转化生长因子-β在生理性和病理性肝脏状况下的多效性作用
Biomedicines. 2024 Apr 22;12(4):925. doi: 10.3390/biomedicines12040925.
2
Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease.肝病中基质硬度的调节因子、功能及机械转导途径
Front Physiol. 2023 Jan 12;14:1098129. doi: 10.3389/fphys.2023.1098129. eCollection 2023.
3
Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease.
酒精性肝病的治疗选择现状及间充质干细胞治疗的潜力
Cells. 2022 Dec 21;12(1):22. doi: 10.3390/cells12010022.
4
Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants.根据基础核心启动子/前核心突变对慢性乙型肝炎患者血清肝纤维化标志物的分析。
Sci Rep. 2022 Jun 17;12(1):10261. doi: 10.1038/s41598-022-14285-9.
5
Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.移植后糖尿病和原有肝脏疾病——影响治疗和管理的双向关系。
World J Gastroenterol. 2020 Jun 7;26(21):2740-2757. doi: 10.3748/wjg.v26.i21.2740.
6
Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study.超重儿科患者肝脂肪变性的特征是血浆转化生长因子 β(TGF-β)水平升高和全身性生化紊乱程度增加:一项横断面研究。
Nutrients. 2020 Jun 2;12(6):1650. doi: 10.3390/nu12061650.
7
Next generation sequencing and RNA-seq characterization of adipose tissue in the Nile crocodile (Crocodylus niloticus) in South Africa: Possible mechanism(s) of pathogenesis and pathophysiology of pansteatitis.下一代测序和 RNA 测序分析南非尼罗鳄(Crocodylus niloticus)脂肪组织:胰腺炎发病机制和病理生理学的可能机制。
PLoS One. 2019 Nov 18;14(11):e0225073. doi: 10.1371/journal.pone.0225073. eCollection 2019.
8
CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.大麻素 1 型受体阻断剂可改善严重失控型糖尿病大鼠肝脂肪浸润和炎症,并增加 Nrf2-AMPK 通路。
PLoS One. 2018 Oct 26;13(10):e0206152. doi: 10.1371/journal.pone.0206152. eCollection 2018.
9
Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy.接受抗病毒治疗的慢性丙型肝炎患者血清转化生长因子-β1水平的变化
Ann Gastroenterol. 2016 Jan-Mar;29(1):79-84.
10
Liver Failure Impairs the Intrahepatic Elimination of Interleukin-6, Tumor Necrosis Factor-Alpha, Hepatocyte Growth Factor, and Transforming Growth Factor-Beta.肝衰竭会损害肝脏对白细胞介素-6、肿瘤坏死因子-α、肝细胞生长因子和转化生长因子-β的清除能力。
Biomed Res Int. 2015;2015:934065. doi: 10.1155/2015/934065. Epub 2015 May 21.